California State University - Interdisciplinary Cancer Meeting (CSU-ICM)
California State University - Interdisciplinary Cancer Meeting (CSU-ICM)
批准号:
10539868
负责人:
Jonathan Kelber
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-07-31
关键词:
AddressAdvocateBasic ScienceBiological SciencesBiomedical ResearchCOVID-19CaliforniaCamellia sinensisCancer BiologyCancer ScienceCancer SurvivorClinicalCollaborationsCommunitiesDataDevelopmentDisciplineDoctor of PhilosophyEarly DiagnosisEnsureEventFacultyFeedbackFosteringFundingGeographyGrantInstitutesInstitutionInvestigationKnowledgeLeadLearningLifeMalignant NeoplasmsNeoplasm MetastasisOncologyParticipantPatientsPerformancePreparationResearchResearch PersonnelResistanceSchoolsScientific Advances and AccomplishmentsScientistSeminalSiteUnited States National Institutes of HealthUniversitiesVisceralWorkanticancer researchbasecancer typecareer networkingdemographicsdesigngraduate studentinnovationinsightinter-institutionalinterdisciplinary approachlectureslow socioeconomic statusmeetingsmortalitynovelpostersprogramsracial disparitysocioeconomicssuccesssymposiumtumortumor microenvironmentundergraduate studentunderrepresented minority studentvirtual
中文摘要
R13应用
凯尔伯、塔梅、德·贝拉尔
标题:加州州立大学-跨学科癌症会议(CSU-ICM)
项目摘要
所有癌症类型的平均死亡率保持在30%以上。发展
针对肿瘤学研究中的核心问题,我们已经建立了
两年一度的加州州立大学跨学科癌症会议(CSU-ICM)。
此应用程序将支持2022年肿瘤微环境会议:
挑战与机遇,将于周五举行,10月21日在加州
州立大学北岭,太阳广场表演厅。本次会议讨论了
需要癌症研究会议,提供负担得起的和重点突出的平台,
生命科学家、非生命科学家和癌症专家之间的跨学科交流。
首届2018 CSU-ICM欢迎Joan Brugge博士和150多名与会者。的
由于COVID 19,2020年的第二个CSU-ICM是虚拟的,但取得了巨大成功,
欢迎卡洛斯·阿特阿加博士和70多名与会者。本申请基于
从2018年和2020年的活动中收集的初步数据表明,
在种族、学科、地理和机构各级的参与。我们推测
这次会议的战略扩展将激发新的合作调查路线
这导致了癌症研究的变革性进展,并增加了癌症研究的多样性。
肿瘤学研究简短的谈话会议将由教师领导主持,
围绕培训生演示设计-提高那些
传统上在癌症研究中代表性不足。癌症幸存者的参与-
支持者将强调,即使是最基本的科学研究,
都是基于清晰的个人视角世界知名的全体演讲者确保
最高质量的科学交流。研究生院信息会议将
为本科生和硕士研究生提供一个有形的渠道,
有关计划和应用程序的细节从教师代表有意义的见解,在
顶级R1机构。最后,海报会议旨在促进科学
交流、建立联系的机会和对正在进行的工作的建设性反馈。在
总结,CSU-ICM旨在促进科学知识,学习,
发现;促进专业发展;和准备一个多样化的科学
同时也满足了更广泛的癌症研究的重要需求
社区
英文摘要
R13 Application
Kelber, Tamae, De Bellard
Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM)
PROJECT SUMMARY
The average mortality across all cancer types remains at over 30%. To develop
transformative solutions to central problems in oncology research, we have established
the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM).
This application is to support the 2022 meeting on The Tumor Microenvironment:
Challenges and Opportunities that will be held on Friday, October 21 at the California
State University Northridge, Plaza del Sol Performance Hall. This meeting addresses the
need for cancer research meetings that provide affordable and focused platforms for
interdisciplinary exchange between life scientists, non-life scientists and cancer experts.
The inaugural 2018 CSU-ICM welcomed Dr. Joan Brugge and over 150 participants. The
second CSU-ICM in 2020 was virtual due to COVID19 but was a big success and
welcomed Dr. Carlos Arteaga and over 70 participants. This application is based upon
preliminary data collected from the 2018 and 2020 events demonstrating diversity of
participation at ethnic, discipline, geographic and institute levels. We postulate that
strategic expansion of this meeting will stimulate novel, collaborative lines of investigation
that lead to transformative advances in cancer research and increase diversity in
oncology research. The short talk sessions will be chaired by faculty leaders and
designed around trainee presentations - increasing the upward mobility of those
traditionally underrepresented in cancer research. Involvement of cancer survivor-
advocates will underscore the need to ensure that even the most basic science research
is grounded in clear personal perspective. The world-renowned plenary speakers ensure
the highest quality of scientific exchange. The graduate school information session will
provide a tangible conduit for undergraduate and masters-level graduate students to gain
meaningful insights about program and application details from faculty representatives at
top-tier R1 institutions. Finally, the poster session is designed to foster scientific
exchange, networking opportunities and constructive feedback on work-in-progress. In
summary, the CSU-ICM is designed to advance scientific knowledge, learning, and
discovery; promotion of professional development; and preparation of a diverse scientific
workforce while also fulfilling an important need in the broader cancer research
community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-Transcriptional Mechanisms of PEAK1 Action During TGFbeta-Induced EMT
-
批准号:9208078
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10546451
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10724839
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10545794
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10088942
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10613025
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
SPATIOTEMPORAL MECHANISMS OF EIF5A1/2-MEDIATED METASTASIS IN TRIPLE-NEGATIVE BREAST CANCER
-
批准号:10374539
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
-
批准号:10360453
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2017
-
负责人:Jonathan Kelber
-
依托单位:
海外基金